WillItSurvive
Pharma and healthcare groups · subsidiary of Lippo Group (via PT Lippo Karawaci Tbk, 20.63% stake); also co-controlled by CVC Capital Partners and Sight Investment Company following 2024 transactions · Indonesia

Siloam Hospitals Group

siloamhospitals.com ↗

Indonesia's largest private hospital chain, 41 hospitals across 23 provinces.

Hard to displace
Assessed 26 July 2026 · Evidence as of 26 July 2026
Strong structural protection; the business model survives ai pressure.
On the recordSince 26 July 2026 · Checkable from 31 Oct 2026 · Every call on the record Checkpoint: First REIT put option on 6 additional hospitals expires, testing post-acquisition leverage
The call

Siloam's size, licenses, and insurer contracts keep it ahead of rivals; rupiah risk and post-REIT leverage matter more than any AI product.

Siloam Hospitals Group runs 41 hospitals across Indonesia and makes money treating patients through insurance and out-of-pocket payments. It is genuinely hard for rivals like IHH Healthcare or Thai hospital companies to copy because they would need to build hospitals from scratch, get government permits, and spend years building relationships with insurance companies and regulators, all taking years and billions of dollars. The main threat is not a competitor but Indonesia's currency (the rupiah) weakening, which would hurt the company's value even if the hospitals themselves keep running well, plus the company took on a lot of debt to buy real estate in 2026 that could squeeze profits if things go wrong.

Why
01
AI pressure: None apparent. AI reads scans and speeds records via the Philips and AWS tie-ups, but beds, doctors, and licenses still decide who gets treated. Could AI do the core job? Unlikely.
02
Bigger players: Hermina Hospital Group, IHH Healthcare. Hermina and regional chains like IHH keep expanding, but matching Siloam's 41-hospital footprint and insurer contracts takes years, not a product launch. Could a giant copy it? No, they are blocked.
03
What protects it. BPJS and private insurer network status, JCI accreditation, and owned real estate across 23 provinces that rivals cannot fast-track.
What would change this call
First REIT's put option on 6 hospitals resolves by 31 Oct 2026. Shows whether Siloam's balance-sheet leverage rises materially post-transaction.
Indonesia's sovereign credit rating outlook (Negative as of Q1 2026) is reviewed or changed. Indicates currency and margin risk to rupiah-denominated hospital revenue.
Private insurer co-pay renegotiations reported in Siloam's 2026 quarterly earnings. Would show whether margin drag flagged Nov 2025 is recurring or one-off.
Key numbers
  • 41 hospitals, ~25-30 clinics, 23 provinces (Jan 2025)
  • Rp1.11tn FY25 net income, up from Rp902B (Apr 2026)
  • 29-30% EBITDA margin forecast FY25 (Nov 2025)
Named risks
  • Indonesia sovereign outlook downgraded to Negative in Q1 2026, threatening rupiah-denominated margins. Severity: high
  • First REIT put option on six more hospitals worth S$294.8m must be resolved by 31 October 2026. Severity: medium
  • Private insurance co-pay renegotiation friction flagged as ongoing margin drag in November 2025. Severity: medium
  • Hermina or other private chains could erode share in Siloam's premium urban markets over time. Severity: low
  • Brand confusion with unrelated US entities Siloam Health and Siloam Vision AI ophthalmology platform. Severity: low
Rivals, as read in July 2026
RivalDirectionEvidence
PT Medikaloka Hermina TbkcontestingHermina runs 52 hospitals vs Siloam's 41, though Siloam led relative market share per June 2024 academic study
Government hospitals (public sector)contestingPublic hospitals held about 51.4% of Indonesia's hospital market per Oct 2020 dataset cited 2024-06-13
PT Mitra Keluarga Karyasehat TbkcontestingComparable market cap peer, ~Rp24-27tn, ranked below Siloam in relative market share study
IHH Healthcare and Thai hospital operatorscontestingRegional giants face multi-year capex, licensing, and insurer-network barriers to entering Indonesia
Questions people ask
Is Siloam Hospitals profitable in 2026?
Yes. Siloam reported FY2025 net income attributable to owners of Rp1,112.7 billion, up from Rp902.2 billion in 2024, on revenue of Rp12.85 trillion, per its Q4 2025 results published 2026-04-06.
Who owns Siloam Hospitals Group?
PT Lippo Karawaci Tbk holds about 20.63% as of 2026-04-12. CVC Capital Partners invested over US$1B in 2024, and Sight Investment Company completed a 45% stake purchase from Lippo Karawaci and Gateway Partners in September 2024.
Could AI replace Siloam Hospitals or its doctors?
No. Siloam's core is physical hospital care, licensed physicians, and regulated liability that AI cannot substitute. It uses AI as a tool via an October 2024 Philips MoU and an August 2025 AWS migration for radiology, EMR summarization, and inventory forecasting.
Who is Siloam Hospitals' biggest competitor?
PT Medikaloka Hermina Tbk, which operates 52 hospitals across 63 cities in 17 provinces as of December 2024, is Siloam's closest private rival, though a June 2024 academic study ranked Siloam highest by relative market share in Indonesia.
How many hospitals does Siloam Hospitals operate?
As of January 27, 2025, Siloam operated 41 hospitals and roughly 25 to 30 clinics across 23 provinces in Indonesia, making it the country's largest private hospital chain by footprint, per Marubeni's partnership announcement.
Is Siloam Hospitals exposed to Indonesia's economic risk?
Yes. Indonesia's sovereign outlook was revised to Negative in Q1 2026, a factor First REIT cited when exiting its Indonesian hospital holdings on 2026-04-07, which could pressure Siloam's rupiah-denominated margins going forward.
Timeline
  • 2026-07-21First REIT unitholders approve Siloam Indonesian hospital divestment at EGM
  • 2026-07-04TTM revenue reaches Rp13.09 trillion, up 7.13% YoY
  • 2026-04-12Lippo Karawaci holds about 20.63% of Siloam shares
  • 2026-04-07Indonesia sovereign outlook revised to Negative
  • 2026-04-06FY2025 net income reported at Rp1.11 trillion, up from Rp902 billion
  • 2025-11-25Q3 2025 net profit rises 19% YoY to Rp797.1 billion
  • 2025-11-07BRI Danareksa forecasts FY25 EBITDA margin of 29-30%
  • 2025-08-15Siloam completes migration of hospital IT systems and MySiloam app to AWS
  • 2025-01-27Siloam deepens strategic partnership with Marubeni Corporation
  • 2024-09-30Sight Investment Company completes 45% stake acquisition for IDR16.7 trillion
Revision history
26 July 2026
First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.
In the same band
Vertex PharmaceuticalsTenet HealthcareIntuitive Surgical
More in Pharma and healthcare groups →
Sources